A recent study reveals that patients who stop using popular GLP-1 drugs like Wegovy and Mounjaro tend to recover shed pounds at a significantly accelerated pace than those who halt conventional diet and exercise regimens.
Research printed in a leading health publication demonstrates that while overweight people often shed substantial amounts of their body weight while on the medication, the mass comes back at an estimated rate of nearly a kilo each month after stopping.
"People using such treatments should be cognizant of the potential of quick rebound weight gain when the treatment is stopped," stated expert Dr. Susan Jebb.
Such speed of recovery implies a return to pre-treatment mass within about a year and a half.
Weighing Therapies
The study, which looked at 37 of trials involving over 9,000 of patients, contrasted the outcomes of GLP-1 agonists with conventional dieting.
Researchers emphasize that people who shed pounds through diet and exercise typically see a less rapid weight regain—around 100 grams monthly—post-intervention.
Explaining the Quick Regain
Experts believe the mechanism of the drugs accounts for the amplified weight return.
These medications copy a natural hormone called GLP-1, which helps regulate appetite.
"Artificially providing the hormone levels far above than normal may cause the body to produce less of its own natural GLP-1, and could diminish sensitivity to its effects," explained Dr. Adam Collins, a nutrition expert.
"Discontinuation of this hormone supplement results in hunger is unsuppressed, making overeating much more probable."
A Lifelong Condition?
Medical guidelines advise the jabs for individuals with weight-linked health risks, alongside recommended diet and exercise modifications.
A number of clinicians contend that, due to the likelihood of relapse, the treatment is often life-long.
This opinion is reinforced by pharmaceutical companies, who say that the findings "highlight the long-term character of excess weight," comparing it to managing diseases like high blood pressure.
Patient Experiences
Users who have stopped the medication describe a sudden resurgence of appetite.
"It was like something flipping and I was suddenly starving," described one woman.
This difficulty is worsened if patients have not adopted permanent dietary or behavioural modifications during treatment.
Growing Interest
Figures show that millions of people in the UK have used these injections in the last 12 months, with desire being substantial.
- Adoption is higher among women compared to men.
- The middle-aged age group shows the greatest level of interest.
- Many access the medications through private prescriptions rather than public health services.
Finally, researchers caution that while the jabs are potent agents for shedding pounds, they are not a magic solution and long-term success relies on integrated behavioural changes.